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ABSTRACT 
Glycyrrhiza glabra Linn. is an Indian medicinal plant demonstrated to exert multiple health cures. This plant grows naturally in tropical, 
subtropical and temperate regions. It is traditionally used as anti-acne, anti-arthritic, anti-convulsant, anti-diabetic, anti-microbial, anti 
inflammatory, wound healing, anti-oxidant, anti-platelet, anti-stress and nootropic, anti-viral, diuretic and gastroprotective. The 
antihyperlipidemic effect of ethanolic root extracts of Glycyrrhizaglabrawas studied in wistar rats using High Fat Diet (FD) induced 
hyperlipidemic model, at the doses of 400 mg/kg body weight. The efficacy of extract was compared with standard drug simvastatin. The 
ethanolic extracts, significantly decreased the serum lipid profile level in a dose dependent manner in wistar rats. Ethanolic extracts at 400 
mg/kg have shown significant antihyperlipidemic action. These results support the fact that this plant is used traditionally as 
antihyperlipidemic. The study will help in exploring new plant source as an antihyperlipiedemic agent which can minimize the risk and side 
effects as compared to that of conventional medicine.   
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1. INTRODUCTION 
Hyperlipidaemia has been found to be associated with the 
alteration of lipid and lipoproteins metabolism in the onset 
of diabetes mellitus1. Several researches have reported the 
positive correlation of metabolic disorders in lipid and 
lipoproteins metabolism in individuals suffering from 
diabetes to arteriosclerosis2, 3 
 
Figure 1: Hypercholesterolemia 
Hyperlipidemia may be a disorder of lipoprotein 
metabolism manifested as hypertriglyceridemia. 
Hyperlipidemic is a risk factor for gall stone, pancreatitis 
and xanthomas, or coronary artery disease (CAD), 
myocardial infarction (MI), hypertension. CAD could be 
considered as the most common cause of death globally, 
including India, by20204. Till 1990’s there has been 8 % 
increase in CAD’s prevalence rate since 1960’s in urban 
areas this increase has been found to be 2 %5. 
Hyperlipidemic, being one of a major complication of CAD 
inflammatory disorder resulting from excessive 
inflammatory response to various forms of injurious 
stimuli to the artery wall6. Medicinal plants play a major 
role in hypolipidemic activity and inhibition of hepatic 
cholesterol biosynthesis and reduction of lipid absorption 
in the intestine7. 
2. MATERIALS AND METHODS                                                
2.1. Materials  
2.1.1. Plant Materials and Authentication 
Roots of Glycyrrhiza glabra Linn, (2kg) were collected from 
local area supplier of Delhi, during the month of March 
2017. Sample of plant material was sent to Department of 
Botany National Institute of Science Communication and 
Information Resources, (NISCAIR) Delhi-110011, for 
identification and taxonomic authentication.  
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2.2.2 Experimental Animals 
Wistar rat either sex, weighing 150-250g purchased from 
All India Institute of Medical Sciences animal house, New 
Delhi. All test animals are allowed free access to food and 
water ad libitum, both being withdrawn just prior to 
experimentation.  
2.2 Methods 
2.2.1. Preparation of plant extract of Glycyrrhiza 
glabra3, 6 
The roots of plant Glycyrrhiza glabra were collected from 
Delhi and were authenticated. The roots of the plant were 
collected and subjected to shade drying. The size were 
reduced and made to coarse powder and then further 
passed through the appropriate sieve no. to obtain uniform 
particle size. The powdered root part extracted with 
ethanol and water by soxhlet apparatus. The root extracts 
were filtered and collected, and concentrated by using 
Rotatory Flash Evaporator. The extracts were used for the 
further experimental models. 
 
Figure 2: Root of Glycyrrhiza glabra 
2.2.2. Determination of Body Weight 
The weight of individual rat of each group was measured 
‘only’ before and after administration of extract. 
 
2.2.3 Animal grouping, feeding and extract 
administration 
2.2.3.1. Experimental design: 
Animals were fasted for 24 hours before the experiment 
with free access to water. 
2.2.3.2. Preparation of drugs 
The ethanolic root extract of Glycyrrhiza glabra will be 
suspended in 2% Tween80 and used for oral 
administration. Each time fresh preparations of the 
extracts were prepared. 
2.2.3.3. Assessment of Antihyperlipidemic Activity 3, 6 
Model- High Fat Diet (FD) induced hyperlipidemic model 
used for study. 
Preparation of Feed 
Normal animal food pellets was crushed in mortar and 
pestle to crush into small pieces and then grinded into fine 
powder in mixer grinder. The other ingredients i.e. 
cholesterol 2% , Cholic acid 1% , sucrose 40% , and butter 
10% were added in the mixer grinder in an ascending 
order of their quantity and mixed well. This dried powder 
was then mixed with same quantity of water every time to 
make small balls of feed and later this was stored in self 
sealing plastic covers in refrigerator at 2°C to 8°C. The feed 
for normal group was prepared by grinding only the 
normal food pellets and then mixing with water without 
the other excipients. This preparation of feed was done 
once in three days for all the animals. 30 Wistar rats were 
randomly divided into 5 groups each group containing six 
animals. The chronic experimental hyperlipidemia was 
produced by feeding the above prepared food for 21 days. 
The rats were then given ethanolic and aqueous root 
extract of (400 mg/kg, oral) and Simvastatin (10 mg/kg, 
oral) once daily in the morning. During these days, all the 
groups also received fat diet in the same dose as given 
earlier. The hyperlipidemic control i.e., group II animals 
received the hyperlipidemic diet and the vehicle. The 
control group animals received the normal laboratory diet 
and vehicle. 
 
Table 1: Classification of groups according to their doses 
Group N Treatment Dose 
Group I 6 Normal saline 10ml/kg  body wt  (Normal Saline) 
Group II 6 High Cholesterol diet  
Group III 6 High Cholesterol diet+ Simvastatin 10mg/kg body weight 
Group IV 6 Glycyrrhiza glabra ethanolic root  extract of low dose + HFD 200mg/kgbody weight 
Group V 6 Glycyrrhiza glabra ethanolic root  extract of high dose + HFD 400mg/kgbody weight 
N= Number of animals in each group             HFD= High fat diet 
On day 21, animals were anaesthetized with chloroform 
and blood was collected by tail vein. The blood samples 
were centrifuged for 15 min at 2500 rpm to obtain serum. 
The collected serum was analyzed for serum Total 
Cholesterol, Triglycerides, High Density Lipoprotein 
Cholesterol, Low Density Lipoprotein Cholesterol and Very 
Low Density Lipoprotein Cholesterol. 
2.3 Statistical Analysis 
The mean ±S.E.M. values were calculated for each group. 
The data were analyzed using one way ANOVA followed by 
Dunnet’s test. *p ≤0.05 was consider to be statistically 
significant ***P <0.001was very significant, ****P<0.0001 
was extremely significant. 
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3. RESULTS 
Antihyperlipidemic activity of ethanolic root extracts of Glycyrrhiza glabra 
Table 2: Effect of ethanolic extracts of roots of Glycyrrhiza glabra on body weight HCD induced hyperlipidemic rats. 
Day Mean Body weight (gm) (% change in body weight) 
Normal HCD STD Eth. 200 mg/kg Eth. 400 mg/kg 
0th day 138.66 144.44 146.33 144.44 144.83 
5th day 161.33 164.66 165.33 166.50 167.44 
10th day 169.10 179.66 180.00 180.00 181.00 
15th day 178.33 185.33 187.33 185.33 188.00 
20th day 183.66 190.33 192.33 190.33 199.33 
Values are Mean ± S.E.M. (n=6); Significance vs. Control group: ***P < 0.001, **P < 0.01 and *P < 0.05, using one- way ANOVA 
followed by Dunnett’s t test. 
 
 
Figure 3: Effect of the ethanolic root extract of Glycyrrhiza glabra on serum lipid profile levels (mg/dL) at 0th, 5th, 
10th, 15thand 20th Day in HCD induced wistar rats. 
Table 3: Various parameters of antihyperlipidemic activity in wistar rats, using ethanolic root extracts of 
Glycyrrhiza glabra 
Group 
No 
Treatment TC 
(mg/dl) 
TG 
(mg/dl) 
HDL 
(mg/dl) 
VLDL 
(mg/dl) 
LDL 
(mg/dl) 
I Normal 77.77± 4.05 70.15± 6.16 34.81± 1.58 14.03±1.23 27.08± 2.91 
II HCD 183.33±6.67  148.92±6.53 18.51± 1.36  29.77±1.30  135.04±5.47 
III HCD + Simva. (10mg/kg) 103.33±7.1* 97.22±5.28* 31.47±2.54* 19.60±1.0* 51.80±3.7* 
IV HCD + Eth.(200mg/kg) 150.0±10.3* 121.54±3.2* 25.92± 1.58* 24.41±0.7* 99.77± 9.85* 
V HCD + Eth.(400mg/kg) 128.33±6.0* 112.74±5.5* 28.10±2.19*  22.51±1.1* 77.67± 3.97* 
All values were expressed as Mean ± SEM, n.s. (non significant) as compared to vehicle control group. 
-test. 
up (i.e., group I), ANOVA followed by Dunnett’s t-test. 
 
 
 
Figure 4: Effect of Ethanolic extract of Glycyrrhiza glabra on concentrations of TC, TG, HDL, VLDL, and LDL, of rats fed 
high fat containing diet. The values are mean ± S.E.M. for six rats. Groups’ I with II and III, IV, V, VI, VII are compared 
with Group II, ** p<0.01, * p<0.05. 
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4. DISCUSSION 
Plants have formed the basis of sophisticated traditional 
medicine system and natural products make excellent leads 
for new drug development. Approximately 80% of the 
world inhabitants rely on traditional medicine for their 
primary health care and play an important role in the 
remaining health care system of the remaining 20% of the 
population. The World Health Organization (WHO) is 
encouraging, promoting and facilitating the effective use of 
herbal medicine in developing countries for health 
problems. Plants have been used as medicines for 
thousands of years and are used today in their natural form 
as well as in other forms. The importance of plants has 
been forgotten by modern man as a result of his 
dependence on the quick   result of allopathic medicines. 
Plant drugs are being rediscovered because of growing 
awareness of unwanted side effects of modern drugs. The 
plant has been chosen for this study as it was easily 
available and the antihyperlipidemic activity has not been 
reported earlier. Glycyrrhiza glabra, belongs to family 
Fabaceae. Roots of Glycyrrhiza glabra have been suggested 
in the Indian system of medicine for a number of diseases.  
Glycyrrhiza glabra is used as mild laxative, anti‐arthritic, 
antiinflammatory, anti‐biotic, anti‐viral, anti‐ulcer, memory 
stimulant (being MAOinhibitor), anti‐tussive, aphrodisiac, 
anti‐mycotic, estrogenic, antioxidant, anti‐caries agent, 
anti‐neoplastic, anti‐cholinergic, anti‐diuretic, 
hypolipidemic agent. In the present study wistar rats were 
chosen for the antihyperlipidemic activity.  
Hyperlipidemia is a well-known risk factor for 
cardiovascular disease. Atherosclerostic coronary artery 
disease (CAD) is one of the major causes of premature 
death globally and it is expected to be the most important 
cause of mortality. It has been established that nutrition 
plays an important role in the etiology of hyperlipidemias 
and atherosclerosis. Several animal and human studies 
have confirmed the hypercholesterolemic properties of 
saturated fatty acids and cholesterol which include 
increasing total cholesterol and altering lipoprotein pattern 
and whose mechanisms remain under study. Cholesterol 
feeding has been often used to elevate serum or tissue 
cholesterol levels to assess hypercholesterolemia-related 
metabolic disturbances in different animal models. Rats fed 
with a diet supplemented with 100g cholesterol and 50gm 
Cholic acid in coconut oil with egg for 21 days served as the 
experimental model. The mechanism of action of cholic 
acid is twofold: an increase in cholesterol absorption and a 
concomitant suppression of cholesterol 7a-hydroxlyase 
activity that results in decreased cholesterol excretion. 
Cholic acid improves cholesterol absorption by its 
emulsifying property. 24 Wistar rats were randomly 
divided into 4 groups of six each. The chronic experimental 
hyperlipidemia was produced by feeding the above 
prepared food for 21 days. The rats were then given test 
plant extracts i.e., Glycyrrhiza glabra ethanolic root extracts 
(400 mg/kg, oral) and Simvastatin (10 mg/kg, oral) once 
daily in the morning. 
The results have revealed that keeping the animal on HFD 
significantly increased the TC, TG, LDL-C level in serum 
(P<0.05) as compared to rats on normal diet. When HFD 
was coadministered with Glycyrrhiza glabra extracts, the 
elevated levels of TC, TG and LDL-C condition have been 
shown considerabled. It was noted that TC, TG and LDL-C 
lowering activity of ethanolic root extract (400mg/kg) of 
Glycyrrhiza glabra was more significant. There was 
significant elevation in plasma HDL-C in Glycyrrhiza glabra 
treated rats as compared to HFD rats, the efficacy of 
Glycyrrhiza glabra extract in preventing the elevation seen 
in various components of lipid profile under 
experimentally induced hyperlipidemia. Flavonoids are 
reported to increase HDL-C concentration and decrease in 
LDL and VLDL l evels in hypercholesteremic rats. The 
presence flavonoids and polyphenols found in Glycyrrhiza 
glabra extracts could therefore be considered responsible 
for increasing HDL and decreasing LDL and VLDL in 
Glycyrrhiza glabra treated rats. Atorvastatin which was 
used as positive control in this study is a HMG-CoA 
reductase inhibitor. HMG-CoA reduces serum triglyceride 
levels through the modulation of apolipoprotein C-III and 
lipoprotein lipase.Studies have shown that increased 
formation of free radical reactive oxygen species contribute 
to the progression of cardiovascular disease, reactive 
oxygen species induced cardiac disfunction and cardiac 
apoptosis.  
The roots extract of Glycyrrhiza glabra were subjected to 
soxhlet extraction with ethanol extract 14.7 % w/w and 
water extract 11.8 % w/w yielded respectively. 
Phytochemical analysis of the plant extract showed 
different phytoconstituents such as glycyrrhizin, 
glycyrrhizinic acid, glabrin A&B, glycyrrhetol, glabrolide, 
isoglabrolide, isoflavones, coumarins, triterpene sterols. 
High fat diet chosen in the present study contains the 
common ingredients in our daily food. The high fat diet 
used in this study contains saturated fatty acids which 
increases the activity of HMG CoA reductase, the rate 
determining enzyme in cholesterol biosynthesis. This may 
be due to higher availability of acetyl CoA, which 
stimulated the cholesterogenesis rate. Simvastatin 
(10mg/kg oral) and the Glycyrrhiza glabra ethanolic 
extracts (400mg/kg) showed better Antihyperlipidemic 
activity.  
5. CONCLUSION  
The yield of ethanolic roots extract of Glycyrrhiza glabra 
was found to be 14.7 % w/w and 11.8 % w/w respectively. 
Phytochemical analysis of the plant extracts showed the 
presence of different phytoconstituents viz. triterpene, 
saponin, flavonoids, polysaccharides, pectins, simple 
sugars, amino acids, mineral salts, asparagines, bitters, 
essential oil, fat, female hormone estrogen, gums, mucilage 
(Rhizome), protein, resins, starches(30%), sterols, volatile 
oils, tannins, glycosides, and various other substances 8, 9. 
Glycyrrhizin, a triterpenoid compound, accounts for the 
sweet taste of licorice root.  Several phytoconstituents like 
glycyrrhizin, glycyrrhizinic acid, glabrin A&B, glycyrrhetol, 
glabrolide, isoglabrolide, isoflavones, coumarins, triterpene 
sterols and flavonoids are known to have anti-
hyperlipidemic properties. This study has revealed that the 
ethanolic root extract of Glycyrrhiza glabra has significant 
antihyperlipidemic activity. The result of the present study 
suggests that the roots of Glycyrrhiza glabra can be used as 
antihyperlipidemic agent for the prevention and treatment 
of CVD diseases. It was observed that keeping the animals 
on HFD significantly increased the TC, TG, LDL-C level in 
serum (P<0.05) as compared to animals on normal diet. 
When HFD was coadministered with Glycyrrhiza glabra 
extracts, the elevated levels of TC, TG and LDL-C condition 
have shown considerable decline. It was noted that TC, TG 
and LDL-C lowering activity of ethanolic root extracts of 
Glycyrrhiza glabra was more significant. There was 
significant elevation in plasma HDL-C in Glycyrrhiza glabra 
treated rats as compared to HFD rats. In the present study, 
the pharmacological screening has led to the conclusion 
that, ethanolic root extract of Glycyrrhiza glabra has 
significant antihyperlipidemic activity. Hence it can be 
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exploited as an antihyperlipidemic therapeutic agent or 
adjuvant in existing therapy for the treatment of 
hyperlipidemia. 
This study reveals that tested root extract of Glycyrrhiza 
glabra has significant free radical scavenging activity. The 
result of the present study suggests that the roots of 
Glycyrrhiza glabra can be used as a source for the 
management of different diseases.  
The broad spectrum antihyperlipidemic activities of the 
plant extract may be due to its active constitunts like 
glycyrrhizin, glycyrrhizinic acid, glabrin A&B, glycyrrhetol, 
glabrolide, isoglabrolide, isoflavones, coumarins, triterpene 
sterols and flavonoids. This study has demonstrated the 
antihyperlipidemic activities of root extract from 
Glycyrrhiza glabra plant. The antihyperlipidemic activity of 
the plant extract of Glycyrrhiza glabra may play a 
significant role in the prevention and treatment of 
atherosclerosis and other cardiovascular diseases. Thus, 
Glycyrrhiza glabra plant can be considered as an easily 
accessible source of natural antihyperlipidemic.
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